Shares Of Orexigen Soar After It Announces Improved Safety Result
Shares of Orexigen Therapeuetics (OREX) are up about 40% after the company reported that its weight-loss Drug Contrave did not only achieve excellent safety results but also saw improvements in other significant areas. When patients took Contrave they were observed to reduce their risk of a heart attack, reduce the risk of a stroke and/or reduce the…